review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1007/S00430-007-0039-0 |
P698 | PubMed publication ID | 17318575 |
P2093 | author name string | Gerd Gross | |
P2860 | cites work | Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis | Q46926059 |
Efficacy of Human Papillomavirus-16 Vaccine to Prevent Cervical Intraepithelial Neoplasia | Q60441062 | ||
A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions | Q24599668 | ||
Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial | Q28236008 | ||
Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women | Q28271727 | ||
Epidemiologic classification of human papillomavirus types associated with cervical cancer | Q29616213 | ||
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide | Q29617514 | ||
Role of herd immunity in determining the effect of vaccines against sexually transmitted disease | Q34380787 | ||
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial | Q34415030 | ||
Global control of hepatitis B virus infection. | Q34749752 | ||
Immunization with viruslike particles induces long-term protection of rabbits against challenge with cottontail rabbit papillomavirus. | Q35854601 | ||
Efficacy and other milestones for human papillomavirus vaccine introduction | Q35999045 | ||
Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control | Q36065397 | ||
Improving adolescent health: focus on HPV vaccine acceptance | Q36323244 | ||
Vaccines for the prevention of human papillomavirus and associated gynecologic diseases: a review | Q36490571 | ||
Human Papillomaviruses and Their Possible Role in Squamous Cell Carcinomas | Q37711514 | ||
Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer | Q40788937 | ||
Human papillomavirus-associated malignancies in HIV-positive men and women | Q40934611 | ||
Papillomavirus-like particles and HPV vaccine development | Q41585272 | ||
A controlled trial of a human papillomavirus type 16 vaccine | Q44366335 | ||
Women's desired information about human papillomavirus | Q45292274 | ||
Prevention of hepatocellular carcinoma by universal vaccination against hepatitis B virus: the effect and problems | Q45422657 | ||
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial | Q45552005 | ||
The theoretical population-level impact of a prophylactic human papilloma virus vaccine | Q45730281 | ||
P433 | issue | 3 | |
P304 | page(s) | 121-125 | |
P577 | publication date | 2007-02-21 | |
P1433 | published in | Medical Microbiology and Immunology | Q15760239 |
P1476 | title | HPV-vaccination against cervical carcinoma: will it really work? | |
P478 | volume | 196 |
Q36478517 | Attitude and knowledge of Iranian female nurses about human papilomavirus infection and cervical cancer: a cross sectional survey |
Q33344903 | Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities |
Q42193505 | Influence of Brucella abortus lipopolysaccharide as an adjuvant on the immunogenicity of HPV-16 L1VLP vaccine in mice. |
Q34973338 | Knowledge of cervical cancer and screening practices of nurses at a regional hospital in Tanzania |
Q38234231 | Vaccination against infectious diseases: what is promising? |
Q95788212 | [Impact of prophylactic HPV vaccines on dermatology and venereology] |
Search more.